GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Vineet Laboratories Ltd (BOM:543298) » Definitions » Forward PE Ratio

Vineet Laboratories (BOM:543298) Forward PE Ratio : 0.00 (As of Jun. 18, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Vineet Laboratories Forward PE Ratio?

Vineet Laboratories's Forward PE Ratio for today is 0.00.

Vineet Laboratories's PE Ratio without NRI for today is 55.52.

Vineet Laboratories's PE Ratio for today is 55.52.


Vineet Laboratories Forward PE Ratio Historical Data

The historical data trend for Vineet Laboratories's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vineet Laboratories Forward PE Ratio Chart

Vineet Laboratories Annual Data
Trend
Forward PE Ratio

Vineet Laboratories Quarterly Data
Forward PE Ratio

Competitive Comparison of Vineet Laboratories's Forward PE Ratio

For the Chemicals subindustry, Vineet Laboratories's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vineet Laboratories's Forward PE Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Vineet Laboratories's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Vineet Laboratories's Forward PE Ratio falls into.



Vineet Laboratories Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Vineet Laboratories  (BOM:543298) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Vineet Laboratories Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Vineet Laboratories's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Vineet Laboratories (BOM:543298) Business Description

Traded in Other Exchanges
Address
5-5-160, Malleswari Nilayam, Opposite Vishnu Theatre, Chintalakunta, L.B.Nagar, Hyderabad, TG, IND, 500 074
Vineet Laboratories Ltd Formerly known as Ortin Laboratories Limited, Unit-II is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Isopropyl-beta-D-thiogalactopyranoside and Nitrophenyl phosphate disodium salt among others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, manufacture of Drug Intermediates & Bulk Dugs.

Vineet Laboratories (BOM:543298) Headlines

No Headlines